User profiles for Joseph P. Gallant

Joseph P. Gallant

University of Wisconsin
Verified email at wisc.edu
Cited by 157

[HTML][HTML] Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography

OC Ubah, EW Lake, GS Gunaratne, JP Gallant… - Nature …, 2021 - nature.com
Single-domain Variable New Antigen Receptors (VNARs) from the immune system of sharks
are the smallest naturally occurring binding domains found in nature. Possessing flexible …

Imaging fibroblast activation protein alpha improves diagnosis of metastatic prostate cancer with positron emission tomography

HM Hintz, JP Gallant, DJ Vander Griend… - Clinical Cancer …, 2020 - AACR
Purpose: Metastatic castration-resistant prostate cancer (mCRPC) is a lethal, heterogeneous
disease with few therapeutic strategies that significantly prolong survival. Innovative …

Exploitation of CD133 for the targeted imaging of lethal prostate cancer

…, JP Gallant, M Shapovalova, Y Li, P Murugan… - Clinical Cancer …, 2020 - AACR
Purpose: Aggressive variant prostate cancer (AVPC) is a nonandrogen receptor–driven form
of disease that arises in men in whom standard-of-care therapies have failed. Therapeutic …

[HTML][HTML] The development of a novel nanobody therapeutic for SARS-CoV-2

G Ye, JP Gallant, C Massey, K Shi, W Tai, J Zheng… - BioRxiv, 2020 - ncbi.nlm.nih.gov
Combating the COVID-19 pandemic requires potent and low-cost therapeutics. We identified
a novel series of single-domain antibodies (ie, nanobody), Nanosota-1, from a camelid …

Development of an Engineered Single-Domain Antibody for Targeting MET in Non-Small Cell Lung Cancer

NY Luo, RL Minne, JP Gallant… - Bioconjugate …, 2024 - ACS Publications
The Mesenchymal Epithelial Transition (MET) receptor tyrosine kinase is upregulated or
mutated in 5% of non-small-cell lung cancer (NSCLC) patients and overexpressed in multiple …

The role of natural selection in shaping genetic variation in a promising Chagas disease drug target: Trypanosoma cruzi trans-sialidase

JP Gallant, RA Lima-Cordón, SA Justi… - Infection, Genetics and …, 2018 - Elsevier
Rational drug design creates innovative therapeutics based on knowledge of the biological
target to provide more effective and responsible therapeutics. Chagas disease, endemic …

Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial

…, KH Lawrence, DP Leong, PG Joseph, P Magloire… - The Lancet, 2020 - thelancet.com
Background Observational studies have suggested that accelerated surgery is associated
with improved outcomes in patients with a hip fracture. The HIP ATTACK trial assessed …

Unlocking Precision Gene Therapy: Harnessing AAV Tropism with Nanobody Swapping at Capsid Hotspots

MD Hoffmann, JP Gallant, AM LeBeau, D Schmidt - bioRxiv, 2024 - biorxiv.org
Adeno-associated virus has been remarkably successful in the clinic, but its broad tropism is
a practical limitation of precision gene therapy. A promising path to engineer AAV tropism is …

Accelerated surgery versus standard care in hip fracture (HIP ATTACK-1): a kidney substudy of a randomized clinical trial

…, DP Leong, PG Joseph, P Magloire… - American Journal of …, 2022 - ajkd.org
Acute kidney injury (AKI) is a lesser-known complication of hip fracture that may come about
owing to decreased kidney perfusion and heightened inflammation from trauma, pain, …

Discovery of 2, 4-bis-arylamino-1, 3-pyrimidines as insulin-like growth factor-1 receptor (IGF-1R) inhibitors

…, L Chai, R Cupples, LF Epstein, P Gallant… - Bioorganic & medicinal …, 2011 - Elsevier
The insulin-like growth factor-1 receptor (IGF-1R) plays an important role in the regulation of
cell growth and differentiation, and in protection from apoptosis. IGF-1R has been shown to …